Figure 5.

Providing a platelet-rich plasma (PRP) treatment to the site of the skin injury helps the structural recovery in terms of speediness and the performant regeneration of affected cutaneous components. Considering the myriad of growth factors and cytokines, it is attractive to presume that PRP is eliciting the vascular recovery of telocytes (TCs), cells with a documented angiogenic potential within the interstitia of other organs. Inset: platelets could stimulate the involvement of TCs (by their cellular prolongations—telopodes) as nursing cells for the new-formed blood vessels. Plt—platelets; RBC—red blood cells; End—endothelial cell; Ma—macrophage; Fb—fibroblast; Ly—lymphocyte; Eo—eosinophil; PMN—neutrophil. The image was created with BioRender.com.